Johnson & Johnson
Recent News About Johnson & Johnson View More
-
Philadelphia now the top-ranked 'Judicial Hellhole'; Massive verdicts, like $8B Risperdal case, cited
WASHINGTON – In an annual report of “Judicial Hellholes” released today by the American Tort Reform Association, Philadelphia has claimed the No. 1 ranking – in part due to a historic $8 billion punitive damages verdict rendered this year in litigation connected to Johnson & Johnson’s anti-psychotic drug Risperdal. -
Oklahoma judge feeds the 'monster' with $572M opioid ruling against Johnson & Johnson
Sixteen years ago in a case involving gunmaker Sturm, Ruger & Co., a New York appeals court refused to apply public nuisance law against the manufacturer of a legal product, saying that doing so would transform nuisance law “into a monster that would devour in one gulp the entire law of tort.” -
Private lawyers stand to make $90 million as judge hits Johnson & Johnson with $572M opioid ruling
NORMAN, Okla. (Legal Newsline) - A state judge in Oklahoma has blamed Johnson & Johnson for the state's opioid crisis and ordered it to pay $572 million in damages, extending public nuisance law beyond its traditional boundaries into what may become an all-purpose tool for government lawsuits against product manufacturers. -
Tensions run high in OK opioid trial Thursday; State focuses on risk data J&J relied on
NORMAN, Okla. (Legal Newsline) - Tensions ran high in court Thursday as the Oklahoma opioid trial continued, with defense attorney Larry Ottoway objecting throughout the day to opposing counsel's line of questioning directed at defense witness, business director for Janssen Pharmaceuticals Kimberly Deem-Eshleman. -
Father recounts loss of son in Oklahoma Johnson & Johnson opioid trial
NORMAN, Okla. (Legal Newsline) – Fighting back tears, a father who lost his son to an opioid overdose recounted the nightmare during testimony in a trial alleging that Johnson & Johnson flooded the state with addictive drugs for profit. -
Hunter: Case is about abating 'worst' man-made crisis; J&J: Case is about damages - not abatement
NORMAN, Okla. (Legal Newsline) - Admitting there is a high potential for abuse in opioid medications, Johnson & Johnson attorney Larry Ottaway said during opening arguments on Tuesday that physicians prescribing its medications Nucynta and Duragesic know this risk and have to know it to be licensed. -
Xarelto litigation resolved with $775M global settlement; Louisiana federal court, Philadelphia's CLC handled most cases
PHILADELPHIA – Though juries had sided with defendants in early trials, more than 27,000 federal and state court lawsuits nationwide surrounding blood-thinner Xarelto have culminated in a global settlement of $775 million with its makers admitting no liability. -
Multidistrict litigation swamps courts as rules struggle to catch up; Is reform on the way?
Multidistrict litigation – sprawling cases sometimes involving thousands of plaintiffs from all over the country – now represents more than half of the civil caseload in federal courts, according to a new survey, yet defendants complain the rules governing them are largely judge-made and haphazardly enforced. -
Louisiana watchdog group says more claims will follow Johnson & Johnson talc powder case
In the wake of the recent $4.69 billion court ruling against Johnson & Johnson over dozens of women claiming to have developed ovarian cancer after years of using the company's talcum powder products, a Louisiana watchdog group says similar cases will likely arise in the future. -
Louisiana Coalition for Common Sense director: Talc verdict indicative of St. Louis' 'judicial hellhole' standing
Jim Harris thinks the nearly $5 billion plaintiff award in the latest Johnson & Johnson asbestos trial says more about the jurisdiction where the verdict was rendered than it does about the strength of the evidence presented by the plaintiffs.